Innovator US Equity Buffer ETF September
BSEP
65 hedge funds and large institutions have $73.1M invested in Innovator US Equity Buffer ETF September in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 15 closing their positions.
7.45% less ownership
Funds ownership: 67.66% → 60.21% (-7.4%)
13% less funds holding
Funds holding: 75 → 65 (-10)
31% less capital invested
Capital invested by funds: $106M → $73.1M (-$32.6M)
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
BSEP Hedge Fund Activity: Q2 2022 in Review
65 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Innovator US Equity Buffer ETF September (BSEP) for Q2 2022, worth a combined $73.1M — down 31% from $106M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of BSEP and 7 opened new positions — a net loss of 8 holders — while 22 trimmed existing stakes and 14 added.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $3.72M. The largest seller was Acute Investment Advisory, exiting entirely with an estimated $4.89M sold.
- 65 institutional investors held Innovator US Equity Buffer ETF September (BSEP) as of Q2 2022, down from 75 in Q1 2022.
- Funds reported $73.1M of Innovator US Equity Buffer ETF September stock for Q2 2022, down 31% quarter-over-quarter.
- 7 funds opened new Innovator US Equity Buffer ETF September positions in Q2 2022 and 15 closed out, a net change of -8 holders.
- The largest Innovator US Equity Buffer ETF September buyer in Q2 2022 was Old Mission Capital, an estimated $3.72M added.
- The largest Innovator US Equity Buffer ETF September seller in Q2 2022 was Acute Investment Advisory, an estimated $4.89M sold.
Based on aggregated 13F filings for Q2 2022.